{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:31:41Z","timestamp":1792956701003,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T00:00:00Z","timestamp":1705190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jinf.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:12:36Z","timestamp":1707869556000},"page":"106104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antibiotics to eradicate Streptococcus pyogenes pharyngeal carriage in asymptomatic children and adults: A systematic review"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-4074","authenticated-orcid":false,"given":"Te-Yu","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linny K.","family":"Phuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7809-7688","authenticated-orcid":false,"given":"Anneke","family":"Grobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Y.C.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pippin","family":"Freeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asika","family":"Pelenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine B.","family":"Gibney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2024.01.003_bib1","first-page":"1","article-title":"The fall and rise of Group A Streptococcus diseases","volume":"147","author":"Barnett","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2024.01.003_bib2","unstructured":"World Health Organization. Disease Outbreak News; Increased incidence of scarlet fever and invasive Group A Streptococcus infection\u2014multi-country. \u3008https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON4292022\u3009."},{"issue":"1","key":"10.1016\/j.jinf.2024.01.003_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942","article-title":"Increase in invasive group A streptococcal infection notifications, England, 2022","volume":"28","author":"Guy","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jinf.2024.01.003_bib4","unstructured":"Sutton B. Health warning on invasive group A streptococcal disease. Health alerts and advisories: Victorian Department of Health; 2022."},{"key":"10.1016\/j.jinf.2024.01.003_bib5","doi-asserted-by":"crossref","unstructured":"Abo Y.-N., Oliver J., McMinn A., Osowicki J., Baker C., Clark J.E., et al. Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges. The Lancet Regional Health\u2014Western Pacific. [In press]. \u3008https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100873\u3009.","DOI":"10.1016\/j.lanwpc.2023.100873"},{"issue":"19","key":"10.1016\/j.jinf.2024.01.003_bib6","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.19.30532","article-title":"Household transmission of invasive group A Streptococcus infections in England: a population-based study, 2009, 2011 to 2013","volume":"22","author":"Mearkle","year":"2017","journal-title":"Euro Surveill."},{"issue":"3","key":"10.1016\/j.jinf.2024.01.003_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2024.01.003_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(05)70190-0","article-title":"Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis?","volume":"5","author":"Smith","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2024.01.003_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM199608223350803","article-title":"Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group","volume":"335","author":"Davies","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.01.003_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/ciu752","article-title":"Global assessment of invasive group a streptococcus infection risk in household contacts","volume":"60","author":"Lamagni","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2024.01.003_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3201\/eid0904.020369","article-title":"Risk for severe group A streptococcal disease among patients' household contacts","volume":"9","author":"Robinson","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2024.01.003_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/oxfordjournals.aje.a009902","article-title":"Streptococcus carriage among close contacts of patients with invasive infections","volume":"149","author":"Weiss","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.jinf.2024.01.003_bib13","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/cid\/ciz716","article-title":"Evaluating household transmission of invasive Group A Streptococcus disease in the United States using population-based surveillance data, 2013-2016","volume":"70","author":"Adebanjo","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2024.01.003_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/bmb\/ldv027","article-title":"Invasive streptococcal disease: a review for clinicians","volume":"115","author":"Parks","year":"2015","journal-title":"Br Med Bull"},{"issue":"2","key":"10.1016\/j.jinf.2024.01.003_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/archdischild-2015-309788","article-title":"QUESTION 1: are household contacts of patients with invasive group A streptococcal disease at higher risk of secondary infection?","volume":"101","author":"Carr","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jinf.2024.01.003_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.697938","article-title":"Invasive Group A Streptococcal infections: benefit of clindamycin, intravenous immunoglobulins and secondary prophylaxis","volume":"9","author":"Laho","year":"2021","journal-title":"Front Pediatr"},{"issue":"11","key":"10.1016\/j.jinf.2024.01.003_bib17","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1017\/S0950268815000849","article-title":"Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review","volume":"143","author":"Telisinghe","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"RR-2","key":"10.1016\/j.jinf.2024.01.003_bib18","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"10.1016\/j.jinf.2024.01.003_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac244","article-title":"Effectiveness and safety of antibiotic prophylaxis for persons exposed to cases of invasive Group A Streptococcal disease: a systematic review","volume":"9","author":"Khan","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2024.01.003_bib20","unstructured":"UK Health Security Agency. UK guidelines for the management of contacts of invasive group A streptococcus (iGAS) infection in community settings; 2022."},{"issue":"2","key":"10.1016\/j.jinf.2024.01.003_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/pch\/pxz039","article-title":"Invasive Group A Streptococcal disease: management and chemoprophylaxis","volume":"24","author":"Moore","year":"2019","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.jinf.2024.01.003_bib22","series-title":"Public Health Management of Invasive Group A Streptococcal Disease in the Northern Territory Guideline","author":"Nancy Merridew","year":"2022"},{"issue":"8","key":"10.1016\/j.jinf.2024.01.003_bib23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/342692","article-title":"Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention","volume":"35","author":"Prevention of Invasive Group A Streptococcal Infections Workshop Participants","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2024.01.003_bib24","article-title":"Different antibiotic treatments for Group A Streptococcal pharyngitis","volume":"3","author":"van Driel","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"10.1016\/j.jinf.2024.01.003_bib25","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.15.2200573","article-title":"Time to negative throat culture following initiation of antibiotics for pharyngeal Group A Streptococcus: a systematic review and meta-analysis up to October 2021 to inform public health control measures","volume":"28","author":"McGuire","year":"2023","journal-title":"Euro Surveill"},{"issue":"9","key":"10.1016\/j.jinf.2024.01.003_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol"},{"issue":"1 Pt 1","key":"10.1016\/j.jinf.2024.01.003_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(05)81052-2","article-title":"Clindamycin treatment of chronic pharyngeal carriage of group A streptococci","volume":"119","author":"Tanz","year":"1991","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jinf.2024.01.003_bib28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(85)80229-8","article-title":"Penicillin plus rifampin eradicates pharyngeal carriage of Group A Streptococci","volume":"106","author":"Tanz","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2024.01.003_bib29","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jinf.2024.01.003_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/000992288502400606","article-title":"Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic Streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin","volume":"24","author":"Brook","year":"1985","journal-title":"Clin Pediatr"},{"issue":"8","key":"10.1016\/j.jinf.2024.01.003_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/14787210.2017.1358612","article-title":"Management of children with persistent Group A Streptococcal carriage","volume":"15","author":"Zacharioudaki","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"10.1016\/j.jinf.2024.01.003_bib32","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/508773","article-title":"Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications","volume":"43","author":"Kaplan","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2024.01.003_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1469-0691.2000.00001.x","article-title":"Pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae in a respiratory chemoprophylaxis intervention study using azithromycin","volume":"6","author":"Putnam","year":"2000","journal-title":"Clin Microbiol Infect"},{"issue":"7-8","key":"10.1016\/j.jinf.2024.01.003_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.14745\/ccdr.v44i78a06","article-title":"Community outbreak of invasive group A streptococcus infection in Ontario, Canada","volume":"44","author":"Dickson","year":"2018","journal-title":"Can Commun Dis Rep"},{"issue":"9560","key":"10.1016\/j.jinf.2024.01.003_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jinf.2024.01.003_bib36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.jinf.2024.01.003_bib37","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/cix921","article-title":"Outbreak of invasive infections from subtype emm26.3 Group A Streptococcus among homeless adults-Anchorage, Alaska, 2016-2017","volume":"66","author":"Mosites","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2024.01.003_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105258","article-title":"A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: a systematic review","volume":"99","author":"Rafei","year":"2022","journal-title":"Infect Genet Evol"},{"issue":"5","key":"10.1016\/j.jinf.2024.01.003_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1586\/14787210.2015.1023292","article-title":"Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies","volume":"13","author":"Silva-Costa","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jinf.2024.01.003_bib40","series-title":"AURA 2021: Fourth Australian Report on Antimicrobial Use and Resistance in Human Health","author":"Australian Commission on Safety and Quality in Health Care","year":"2021"},{"issue":"11","key":"10.1016\/j.jinf.2024.01.003_bib41","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/cid\/ciab575","article-title":"Patterns of antibiotic nonsusceptibility among invasive Group A Streptococcus infections-United States, 2006-2017","volume":"73","author":"Fay","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2024.01.003_bib42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/cid\/ciac468","article-title":"Continued increase of erythromycin nonsusceptibility and clindamycin nonsusceptibility among invasive Group A Streptococci driven by genomic clusters, United States, 2018-2019","volume":"76","author":"Li","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2024.01.003_bib43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2666-5247(21)00332-3","article-title":"Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK","volume":"3","author":"Cordery","year":"2022","journal-title":"Lancet Microbe"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:38:38Z","timestamp":1759009118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0163445324000227"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.01.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotics to eradicate Streptococcus pyogenes pharyngeal carriage in asymptomatic children and adults: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106104"}}